Active Ingredient(s): Interferon Alfacon-1
FDA Approved: * October 6, 1997
Category: Hepatitis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Infergen Overview

Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1] References ^ DrugBank DB00069 .mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}...

Read more Infergen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Infergen Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Interferon Alfacon-1
  • Injection: 15mcg/0.5ml, 30mcg/ml, 9mcg/0.3ml
  • Vial: 30ug/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Infergen: (2 results)

Sorted by National Drug Code
  • 66435-201 Infergen .03 mg/ml Subcutaneous Injection by Kadmon Pharmaceuticals, LLC
  • 66435-202 Infergen .03 mg/ml Subcutaneous Injection by Kadmon Pharmaceuticals, LLC

Other drugs which contain Interferon Alfacon-1 or a similar ingredient: (1 result)